topbar

Tag Archives | Devices and Research

Inspri, LLC Releases Generation II Sciata(R) Seating System for Sciatic, Coccyx Pain Management

LAKEWOOD, Colo. (SEND2PRESS NEWSWIRE) — Inspri, LLC, developer of seating systems and cushions for sciatic, low back and coccyx pain sufferers, has unveiled a new type of foam with the release of its second generation Sciata(R) Seating System. Generation II combines Inspri’s proprietary memory-style Sciata(R) Foam with an enhanced version of Inspri’s patented and proven […]

Continue Reading

Social Entrepreneur Competition Runner-Up, DesignWise Medical Adds Four Board Members

MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — DesignWise Medical, a nonprofit pediatric medical device organization and recent runner-up in the Mosaic Social Entrepreneurs Cup competition, announced today that it has added four new members to its board of directors. With the addition of Gwenyth Fischer MD, James Davenport, Al Emola and Phil Kading, the DesignWise Medical board […]

Continue Reading

Compelling Clinical Data Proves VitalStim Therapy Offers Relief from Dysphagia and Swallowing Difficulty

SEATTLE, Wash. (SEND2PRESS NEWSWIRE) — VitalStim(R) Therapy is a patented-therapy process and equipment system developed specifically to treat dysphagia and patients with difficulty swallowing. And, it’s safe and effective. Developed by Marcy L. Freed, MA, CCC-SLP, in response to reports that approximately 15 million Americans live with dysphagia, VitalStim Therapy is a non-invasive, external electrical […]

Continue Reading

Nuclear Medicine Leader Dr. M. Donald Blaufox Leads Cell Point Cancer Diagnostic Phase 2/3 Trial

CENTENNIAL, Colo. (SEND2PRESS NEWSWIRE) — Cell>Point announced today that M. Donald Blaufox, M.D., Ph.D, will be coordinating principal investigator for its Phase 2/3 clinical trial of 99mTc-EC-G for cancer diagnostic imaging. The trial is currently underway. 99mTc-EC-G is the company’s cancer diagnostic imaging agent, an acronym for 99mTechnetium-EthylenediCysteine-Glucosamine.

Continue Reading

MMDI Announces Agreement with Novation to Supply the Rebound HRD

MINNEAPOLIS, Minn. (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that it has been awarded an agreement under Novation’s ‘New Medical Technology’ program to supply its Rebound HRD and Rebound HRD V (hernia repair devices) to their alliance members, which includes: acute hospitals and systems, academic medical centers and ambulatory care facilities. The […]

Continue Reading
MMDI

MMDI's Rebound HRD V Receives FDA 510(k) Clearance

MINNEAPOLIS, Minn., April 29 (SEND2PRESS NEWSWIRE) — Minnesota Medical Development, Inc. (MMDI) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to its new Rebound HRD V (Hernia Repair Device). The Rebound HRD V is intended to assist in the repair and/or reinforcement of hernia or other soft tissue defects […]

Continue Reading

Powered by WordPress. Designed by WooThemes